Interventions for hypertension and stroke

First-in-man percutaneous closure of left atrial appendage using the Ultraseal II device

EuroIntervention 2019;15:e816-e817. DOI: 10.4244/EIJ-D-18-01084

Ignacio Cruz-González
Ignatio Cruz-González1; Rocío González Ferreiro1; Manuel Barreiro Pérez1; Pedro Luis Sánchez Fernández1
1. Servicio de Cardiología, Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Facultad de Medicina, Universidad de Salamanca, y CIBERCV, Salamanca, Spain

Figure 1. First-in-human experience with the Ultraseal II. A) LAA occlusion with the Ultraseal II device and (B) comparison between the first Ultraseal device and the new Ultraseal II.

A 74-year-old man with atrial fibrillation and spontaneous intra-cerebral haemorrhage was admitted for percutaneous closure of the left atrial appendage (LAA). We present the first-in-man experience with the Ultraseal II device (Cardia, Inc., Eagan, MN, USA).

Under conscious sedation, the procedure was carried out using transoesophageal echocardiography (TEE) with an S8-3t microprobe (Philips Medical Systems, Andover, MA, USA) and fluoroscopic guidance. A 22 mm Ultraseal II was ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Interventions for strokeLAA closure
Read next article
Are we compromising on value versus performance: time to consider the Portico valve as a third major market player?

Latest news